Drug intelligence / Profile preview

phleum pratense allergen extract

Development stage
Approved
Lead developer
ALK Abelló
Administration
Sublingual, Subcutaneous
01

Overview

**Phleum pratense allergen extract** is a standardized allergen extract derived from the pollen of *Phleum pratense* (Timothy grass), used in allergen immunotherapy to induce immune tolerance and reduce symptoms of allergic rhinitis and conjunctivitis due to grass pollen allergy. It is administered as a sublingual tablet (SLIT) or as a subcutaneous injection as part of an allergen-specific immunotherapy regimen. The extract contains a mixture of major and minor Timothy grass pollen proteins standardized for consistent potency. Its immunological action includes induction of allergen-specific blocking IgG4 antibodies, modulation of regulatory T-cells, and a shift away from the Th2-mediated allergic response, leading to long-term tolerance and symptom reduction. Primary indications are the treatment and prophylaxis of grass pollen-induced seasonal allergic rhinitis and conjunctivitis in patients with documented sensitization[^1][^3][^8].

Brand names
GrazaxGrastekOralair
Other names
Timothy grass pollen extractPhleum pratense pollenTimothyTimothy grass
02

Targets

Timothy grass-specific IgE (Timothy grass-specific immunoglobulin E)

Beyond the preview

Go deeper on phleum pratense allergen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on phleum pratense allergen extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call